Abner Herrman & Brock’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $355K | Hold |
14,750
| – | – | 0.03% | 83 |
|
|
2026
Q1 | $414K | Sell |
14,750
-249
| -2% | -$6.63K | 0.05% | 74 |
|
|
2025
Q4 | $373K | Buy |
14,999
+249
| +2% | +$6.28K | 0.04% | 86 |
|
|
2025
Q3 | $376K | Hold |
14,750
| – | – | 0.04% | 85 |
|
|
2025
Q2 | $358K | Hold |
14,750
| – | – | 0.04% | 53 |
|
|
2025
Q1 | $374K | Hold |
14,750
| – | – | 0.05% | 51 |
|
|
2024
Q4 | $391K | Buy |
14,750
+1,000
| +7% | +$27.1K | 0.05% | 52 |
|
|
2024
Q3 | $398K | Sell |
13,750
-200
| -1% | -$5.83K | 0.05% | 71 |
|
|
2024
Q2 | $390K | Hold |
13,950
| – | – | 0.05% | 69 |
|
|
2024
Q1 | $387K | Buy |
13,950
+1,136
| +9% | +$31.5K | 0.05% | 66 |
|
|
2023
Q4 | $369K | Buy |
12,814
+1,225
| +11% | +$37K | 0.05% | 72 |
|
|
2023
Q3 | $384K | Sell |
11,589
-365
| -3% | -$12.9K | 0.06% | 69 |
|
|
2023
Q2 | $438K | Buy |
11,954
+141
| +1% | +$5.49K | 0.06% | 68 |
|
|
2023
Q1 | $482K | Hold |
11,813
| – | – | 0.07% | 69 |
|
|
2022
Q4 | $605K | Hold |
11,813
| – | – | 0.09% | 57 |
|
|
2022
Q3 | $517K | Hold |
11,813
| – | – | 0.09% | 56 |
|
|
2022
Q2 | $619K | Buy |
11,813
+2,546
| +27% | +$130K | 0.11% | 55 |
|
|
2022
Q1 | $480K | Sell |
9,267
-204
| -2% | -$10.6K | 0.07% | 67 |
|
|
2021
Q4 | $559K | Buy |
9,471
+924
| +11% | +$45.8K | 0.07% | 68 |
|
|
2021
Q3 | $368K | Sell |
8,547
-103
| -1% | -$4.56K | 0.05% | 73 |
|
|
2021
Q2 | $339K | Sell |
8,650
-38,425
| -82% | -$1.49M | 0.05% | 72 |
|
|
2021
Q1 | $1.71M | Sell |
47,075
-53,787
| -53% | -$1.91M | 0.26% | 50 |
|
|
2020
Q4 | $3.71M | Sell |
100,862
-5,835
| -5% | -$214K | 0.58% | 43 |
|
|
2020
Q3 | $3.71M | Sell |
106,697
-75,212
| -41% | -$2.64M | 0.63% | 44 |
|
|
2020
Q2 | $5.64M | Buy |
181,909
+118,449
| +187% | +$4.02M | 1.01% | 35 |
|
|
2020
Q1 | $1.97M | Buy |
63,460
+34,845
| +122% | +$1.19M | 0.45% | 42 |
|
|
2019
Q4 | $1.06M | Buy |
28,615
+790
| +3% | +$28.1K | 0.16% | 60 |
|
|
2019
Q3 | $949K | Sell |
27,825
-1,051
| -4% | -$38.2K | 0.14% | 61 |
|
|
2019
Q2 | $1.19M | Sell |
28,876
-1,112
| -4% | -$44.2K | 0.17% | 57 |
|
|
2019
Q1 | $1.21M | Sell |
29,988
-149
| -0.5% | -$5.97K | 0.19% | 56 |
|
|
2018
Q4 | $1.25M | Buy |
30,137
+5,225
| +21% | +$217K | 0.23% | 50 |
|
|
2018
Q3 | $1.04M | Buy |
24,912
+705
| +3% | +$27.1K | 0.15% | 68 |
|
|
2018
Q2 | $833K | Buy |
24,207
+1,108
| +5% | +$37.9K | 0.13% | 72 |
|
|
2018
Q1 | $778K | Buy |
23,099
+106
| +0.5% | +$3.64K | 0.12% | 75 |
|
|
2017
Q4 | $790K | Buy |
22,993
+5
| +0% | +$170 | 0.13% | 76 |
|
|
2017
Q3 | $779K | Buy |
22,988
+2,918
| +15% | +$93.8K | 0.14% | 77 |
|
|
2017
Q2 | $640K | Buy |
20,070
+608
| +3% | +$19.2K | 0.12% | 81 |
|
|
2017
Q1 | $632K | Buy |
19,462
+2,640
| +16% | +$83.2K | 0.13% | 73 |
|
|
2016
Q4 | $536K | Sell |
16,822
-417,738
| -96% | -$12.8M | 0.11% | 75 |
|
|
2016
Q3 | $14M | Buy |
434,560
+16,052
| +4% | +$537K | 3.17% | 3 |
|
|
2016
Q2 | $14.4M | Buy |
418,508
+5,354
| +1% | +$171K | 3.34% | 3 |
|
|
2016
Q1 | $11.6M | Buy |
413,154
+103,344
| +33% | +$2.95M | 2.92% | 5 |
|
|
2015
Q4 | $9.49M | Buy |
309,810
+14,187
| +5% | +$446K | 4.89% | 3 |
|
|
2015
Q3 | $9.34M | Buy |
295,623
+11,462
| +4% | +$368K | 4.98% | 2 |
|
|
2015
Q2 | $9.13M | Buy |
284,161
+10,160
| +4% | +$331K | 4.58% | 3 |
|
|
2015
Q1 | $9.04M | Sell |
274,001
-3,151
| -1% | -$100K | 4.6% | 4 |
|
|
2014
Q4 | $8.19M | Buy |
277,152
+229,543
| +482% | +$6.58M | 4.15% | 2 |
|
|
2014
Q3 | $1.34M | Buy |
47,609
+17,839
| +60% | +$501K | 0.39% | 57 |
|
|
2014
Q2 | $838K | Hold |
29,770
| – | – | 0.25% | 59 |
|
|
2014
Q1 | $907K | Buy |
29,770
+9,287
| +45% | +$277K | 0.29% | 59 |
|
|
2013
Q4 | $594K | Buy |
20,483
+3,675
| +22% | +$107K | 0.21% | 65 |
|
|
2013
Q3 | $458K | Sell |
16,808
-3,777
| -18% | -$103K | 0.3% | 66 |
|
|
2013
Q2 | $547K | Buy |
+20,585
| New | +$569K | 0.23% | 68 |
|
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
WAM
Abner Herrman & Brock's PFE Position: Q2 2026 in Review
Abner Herrman & Brock held its Pfizer (PFE) position steady in Q2 2026 at 14,750 shares worth $355K. The position accounts for 0.03% of the portfolio, ranked #83.
Abner Herrman & Brock first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.4M in Q2 2016. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Abner Herrman & Brock held 14,750 shares of Pfizer worth $355K as of Q2 2026.
- Abner Herrman & Brock left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.03% of Abner Herrman & Brock's portfolio in Q2 2026, its #83 holding.
- Abner Herrman & Brock first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Abner Herrman & Brock's Pfizer position peaked at $14.4M in Q2 2016.
- 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.